Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Quinoline compounds >  8-Aminoisoquinoline

8-Aminoisoquinoline

Basic information Safety Supplier Related

8-Aminoisoquinoline Basic information

Product Name:
8-Aminoisoquinoline
Synonyms:
  • 8-AMINOISOQUINOLINE
  • ISOQUINOLIN-8-AMINE
  • ISOQUINOLIN-8-YLAMINE
  • 8-Aminoisoquinoline95%
  • 8-Aminoisoquinoline 98%
  • 8-amine-isoquinoline
  • 8-Isoquinolinamine
  • 8-Aminoisoquinoline ,98%
CAS:
23687-27-6
MF:
C9H8N2
MW:
144.17
EINECS:
691-616-4
Product Categories:
  • Building Blocks
  • Isoquinoline
  • Quinoline&Isoquinoline
  • Amines
  • blocks
  • Quinolines
  • Heterocyclic Series
Mol File:
23687-27-6.mol
More
Less

8-Aminoisoquinoline Chemical Properties

Melting point:
155-157
Boiling point:
335.7±17.0 °C(Predicted)
Density 
1.210±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,2-8°C
form 
Crystalline Powder
pka
6.20±0.23(Predicted)
color 
Brown
InChI
InChI=1S/C9H8N2/c10-9-3-1-2-7-4-5-11-6-8(7)9/h1-6H,10H2
InChIKey
GUSYANXQYUJOBH-UHFFFAOYSA-N
SMILES
C1C2=C(C=CC=C2N)C=CN=1
CAS DataBase Reference
23687-27-6(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
41
Safety Statements 
26-39
Hazard Note 
Harmful/Irritant/Keep Cold
HS Code 
29334900
More
Less

8-Aminoisoquinoline Usage And Synthesis

Chemical Properties

Brown solid

Uses

8-Aminoisoquinoline and its derivatives are used as intermediates for antimalarial drugs in the pharmaceutical field. For example, their structure is similar to the antimalarial drug primaquine.

Synthesis

63927-23-1

23687-27-6

General procedure for the synthesis of 8-aminoisoquinolines from 5-bromo-8-nitroisoquinolines: 5-bromo-8-nitroisoquinolines (1.00 g, 3.95 mmol) were dissolved in methanol (70 mL), and hydrogenation was carried out by adding palladium/activated charcoal (10% Pd, 200 mg) as a catalyst for 18 hr at room temperature and atmospheric pressure. Upon completion of the reaction, the reaction mixture was filtered through Celite to remove the catalyst. The filtrate was concentrated and purified by column chromatography (eluent: ethyl acetate/heptane) to afford the target compound 8-aminoisoquinoline (100 mg, 18% yield) as a greenish-brown solid.1H NMR (DMSO-d6, 400 MHz) δ 9.43 (s, 1H), 8.32 (d, 1H), 7.54 (d, 1H), 7.40 (dd, 1H) , 6.99 (d, 1H), 6.72 (d, 1H), 6.22 (s, 2H).

References

[1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 4, p. 803 - 806
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 3, p. 744 - 752
[3] Patent: WO2009/130481, 2009, A1. Location in patent: Page/Page column 143
[4] Journal of Medicinal Chemistry, 2005, vol. 48, # 15, p. 4972 - 4982
[5] Patent: WO2006/32851, 2006, A1. Location in patent: Page/Page column 49

8-AminoisoquinolineSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com